Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Neoplasia (New York, N.Y.)
|
October 31, 2002
Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization
Gil M Yerushalmi, Raya Leibowitz-Amit, Miriam Shaharabany, et al.
Journal of Assisted Reproduction and Genetics
|
June 14, 2011
Molecular characterization of the human ovulatory cascade-lesson from the IVF/IVM model
Gil M Yerushalmi, Ettie Maman, Yuval Yung, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
March 28, 2014
Comparison between two protocols for thawed embryo transfer: natural cycle versus exogenous hormone replacement
Jacob Levron, Gil M Yerushalmi, Masha Brengauz, et al.
The Journal of Biological Chemistry
|
January 6, 2005
Mislocalization or reduced expression of Arf GTPase-activating protein ASAP1 inhibits cell spreading and migration by influencing Arf1 GTPase cycling
Yunhao Liu, Gil M Yerushalmi, Pablo R Grigera, et al.
Journal of Assisted Reproduction and Genetics
|
January 16, 2018
Comparison of effects of thawing entire donor sperm vial vs. partial thawing (shaving) on sperm quality
Micha Baum, Raoul Orvieto, Sapir Kon, et al.
Journal of Ovarian Research
|
March 2, 2019
HAS2-AS1 is a novel LH/hCG target gene regulating HAS2 expression and enhancing cumulus cells migration
Yuval Yung, Libby Ophir, Gil M Yerushalmi, et al.
Journal of Assisted Reproduction and Genetics
|
April 24, 2013
What is the optimal threshold of serum Anti-Müllerian hormone (AMH) necessary for IVM treatments?
Alon Kedem, Gil M Yerushalmi, Ettie Maman, et al.
Cancer Research
|
September 5, 2006
Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways
Raya Leibowitz-Amit, Galia Tsarfaty, Yamit Abargil, et al.
Journal of Assisted Reproduction and Genetics
|
March 26, 2018
Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation
Alon Kedem, Gil M Yerushalmi, Masha Brengauz, et al.
Fertility and Sterility
|
April 1, 2014
Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
Alon Kedem, Abraham Tsur, Jigal Haas, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Neoplasia (New York, N.Y.)
|
October 31, 2002
Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization
Gil M Yerushalmi, Raya Leibowitz-Amit, Miriam Shaharabany, et al.
Journal of Assisted Reproduction and Genetics
|
June 14, 2011
Molecular characterization of the human ovulatory cascade-lesson from the IVF/IVM model
Gil M Yerushalmi, Ettie Maman, Yuval Yung, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
March 28, 2014
Comparison between two protocols for thawed embryo transfer: natural cycle versus exogenous hormone replacement
Jacob Levron, Gil M Yerushalmi, Masha Brengauz, et al.
The Journal of Biological Chemistry
|
January 6, 2005
Mislocalization or reduced expression of Arf GTPase-activating protein ASAP1 inhibits cell spreading and migration by influencing Arf1 GTPase cycling
Yunhao Liu, Gil M Yerushalmi, Pablo R Grigera, et al.
Journal of Assisted Reproduction and Genetics
|
January 16, 2018
Comparison of effects of thawing entire donor sperm vial vs. partial thawing (shaving) on sperm quality
Micha Baum, Raoul Orvieto, Sapir Kon, et al.
Journal of Ovarian Research
|
March 2, 2019
HAS2-AS1 is a novel LH/hCG target gene regulating HAS2 expression and enhancing cumulus cells migration
Yuval Yung, Libby Ophir, Gil M Yerushalmi, et al.
Journal of Assisted Reproduction and Genetics
|
April 24, 2013
What is the optimal threshold of serum Anti-Müllerian hormone (AMH) necessary for IVM treatments?
Alon Kedem, Gil M Yerushalmi, Ettie Maman, et al.
Cancer Research
|
September 5, 2006
Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways
Raya Leibowitz-Amit, Galia Tsarfaty, Yamit Abargil, et al.
Journal of Assisted Reproduction and Genetics
|
March 26, 2018
Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation
Alon Kedem, Gil M Yerushalmi, Masha Brengauz, et al.
Fertility and Sterility
|
April 1, 2014
Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
Alon Kedem, Abraham Tsur, Jigal Haas, et al.
Page
of 3